Insulin sensitizer C59

C59 is an orally bioavailable small molecule insulin sensitizer that enhances cellular glucose uptake. It serves as a valuable research tool for investigating insulin signaling and GLUT4 translocation mechanisms in both in vitro and in vivo models of insulin resistance and diabetes. Insulin sensitizer C59 is supplied for research use only and is intended for laboratory research involving animal models. Biorbyt supplies these products exclusively to research institutions and commercial laboratories.